[EN] ARYL AND HETEROARYL AMIDE COMPOUNDS AS RORGAMAT MODULATOR<br/>[FR] COMPOSÉS D'ARYL- ET HÉTÉROARYLAMIDE EN TANT QUE MODULATEUR DE RORGammaT
申请人:GLENMARK PHARMACEUTICALS SA
公开号:WO2013171729A2
公开(公告)日:2013-11-21
The present disclosure is directed to compounds of Formula (I), and pharmaceutically acceptable salts thereof, as modulator of retinoid-related orphan receptor gamma t (RORϒt). These compounds prevent, inhibit, or suppress the action of RORϒt and are therefore useful in the treatment of RORϒt mediated disease, disorder, syndrome or condition such as pain, inflammation, COPD, asthma, rheumatoid arthritis, colitis, multiple sclerosis, neurodegenerative diseases or cancer.